Form 3 ARROWHEAD PHARMACEUTICAL For: Feb 06 Filed by: INGRAM DOUGLAS S

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. WCN
6. SPOT
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Form 3 ARROWHEAD PHARMACEUTICAL For: Feb 06 Filed by: INGRAM DOUGLAS S

Chardan Capital Markets Reiterates Buy Rating on Arrowhead Pharma (ARWR)

February 11, 2025 7:46 AM EST

Chardan Capital Markets analyst Keay Nakae reiterated a Buy rating and $60.00 price target on Arrowhead Pharma (NASDAQ: ARWR)

The analyst comments "The company is currently evaluating plozasiran in three other phase III studies: SHASTA-3 and SHASTA-4 in adults with SHTG (currently enrolling), and MUIR-3 in adults... More